Hypermarcas (OTCMKTS:HYPMY) Short Interest Update

Hypermarcas (OTCMKTS:HYPMY) was the recipient of a significant decline in short interest in the month of August. As of August 31st, there was short interest totaling 6,225 shares, a decline of 32.9% from the August 15th total of 9,271 shares. Based on an average daily volume of 7,201 shares, the days-to-cover ratio is presently 0.9 days. Approximately 0.0% of the shares of the company are sold short.

Hypermarcas Trading Down 0.9%

Shares of HYPMY stock traded down $0.04 on Thursday, hitting $4.50. The company had a trading volume of 3,599 shares, compared to its average volume of 4,942. The stock’s 50-day moving average is $4.20 and its two-hundred day moving average is $4.30. Hypermarcas has a twelve month low of $3.71 and a twelve month high of $5.50. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.26 and a current ratio of 1.86. The firm has a market cap of $3.17 billion, a P/E ratio of 9.00 and a beta of 0.71.

Hypermarcas (OTCMKTS:HYPMY) last posted its quarterly earnings results on Thursday, August 6th. The company reported $0.14 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.13 by $0.01. Hypermarcas had a return on equity of 12.68% and a net margin of 19.77%. On average, equities research analysts anticipate that Hypermarcas will post 0.53 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Separately, Jefferies Financial Group upgraded Hypermarcas to a “strong-buy” rating in a report on Monday, July 20th. One investment analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Buy”.

About Hypermarcas

Hypermarcas SA was a Brazilian consumer health and pharmaceutical company that developed, manufactured and marketed branded products for healthcare, personal care and consumer markets. Its portfolio historically included over-the-counter medicines, prescription products, vitamins, toiletries, cosmetics and other household or personal-care brands.

The company expanded through acquisitions and operated primarily in Brazil, building a broad portfolio of locally recognized brands. In the mid-2010s, Hypermarcas began divesting its non-pharmaceutical businesses to concentrate on healthcare and medicines.